The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
ClearPoint Neuro Inc (NASDAQ: CLPT) closed the day trading at $25.05 up 19.80% from the previous closing price of $20.91. In other words, the price has increased by $19.80 from its previous closing price. On the day, 1.89 million shares were traded. CLPT stock price reached its highest trading level at $25.7493 during the session, while it also had its lowest trading level at $20.8.
Ratios:
For a better understanding of CLPT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.45 and its Current Ratio is at 7.30. In the meantime, Its Debt-to-Equity ratio is 1.80 whereas as Long-Term Debt/Eq ratio is at 1.78.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when Richards Timothy T. sold 10,000 shares for $13.28 per share. The transaction valued at 132,800 led to the insider holds 77,381 shares of the business.
BURNETT JOSEPH sold 21,247 shares of CLPT for $282,373 on Jun 09 ’25. The CEO and President now owns 243,522 shares after completing the transaction at $13.29 per share. On Jun 10 ’25, another insider, TIMOTHY RICHARDS, who serves as the Director of the company, bought 10,000 shares for $13.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLPT now has a Market Capitalization of 712106752 and an Enterprise Value of 706021824. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.20 while its Price-to-Book (P/B) ratio in mrq is 36.06. Its current Enterprise Value per Revenue stands at 21.017 whereas that against EBITDA is -32.618.
Stock Price History:
The Beta on a monthly basis for CLPT is 1.29, which has changed by 1.234612 over the last 52 weeks, in comparison to a change of 0.16766965 over the same period for the S&P500. Over the past 52 weeks, CLPT has reached a high of $22.39, while it has fallen to a 52-week low of $9.76. The 50-Day Moving Average of the stock is 103.35%, while the 200-Day Moving Average is calculated to be 85.59%.
Shares Statistics:
Over the past 3-months, CLPT traded about 652.83K shares per day on average, while over the past 10 days, CLPT traded about 2449090 shares per day. A total of 28.42M shares are outstanding, with a floating share count of 24.34M. Insiders hold about 14.39% of the company’s shares, while institutions hold 33.53% stake in the company. Shares short for CLPT as of 1757894400 were 2368518 with a Short Ratio of 3.63, compared to 1755216000 on 2549421. Therefore, it implies a Short% of Shares Outstanding of 2368518 and a Short% of Float of 8.63.
Earnings Estimates
. The current market rating for ClearPoint Neuro Inc (CLPT) reflects the collective analysis of 2.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.19, with high estimates of -$0.18 and low estimates of -$0.19.
Analysts are recommending an EPS of between -$0.8 and -$0.81 for the fiscal current year, implying an average EPS of -$0.81. EPS for the following year is -$0.68, with 2.0 analysts recommending between -$0.67 and -$0.68.
Revenue Estimates
2 analysts predict $9.6M in revenue for. The current quarter. It ranges from a high estimate of $9.9M to a low estimate of $9.3M. As of. The current estimate, ClearPoint Neuro Inc’s year-ago sales were $8.12MFor the next quarter, 2 analysts are estimating revenue of $10.35M. There is a high estimate of $10.7M for the next quarter, whereas the lowest estimate is $10M.
A total of 2 analysts have provided revenue estimates for CLPT’s current fiscal year. The highest revenue estimate was $38.3M, while the lowest revenue estimate was $37M, resulting in an average revenue estimate of $37.65M. In the same quarter a year ago, actual revenue was $31.39MBased on 2 analysts’ estimates, the company’s revenue will be $47.25M in the next fiscal year. The high estimate is $50.3M and the low estimate is $44.2M.
